76 related articles for article (PubMed ID: 9916707)
1. Orientation of the Ig domains of CD8 alpha beta relative to MHC class I.
Devine L; Sun J; Barr MR; Kavathas PB
J Immunol; 1999 Jan; 162(2):846-51. PubMed ID: 9916707
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the roles of CD8 alpha alpha and CD8 alpha beta in interaction with MHC class I.
Sun J; Kavathas PB
J Immunol; 1997 Dec; 159(12):6077-82. PubMed ID: 9550407
[TBL] [Abstract][Full Text] [Related]
3. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
[TBL] [Abstract][Full Text] [Related]
4. Location of the epitope for an anti-CD8alpha antibody 53.6.7 which enhances CD8alpha-MHC class I interaction indicates antibody stabilization of a higher affinity CD8 conformation.
Devine L; Hodsdon ME; Daniels MA; Jameson SC; Kavathas PB
Immunol Lett; 2004 May; 93(2-3):123-30. PubMed ID: 15158607
[TBL] [Abstract][Full Text] [Related]
5. Different features of the MHC class I heterodimer have evolved at different rates. Chicken B-F and beta 2-microglobulin sequences reveal invariant surface residues.
Kaufman J; Andersen R; Avila D; Engberg J; Lambris J; Salomonsen J; Welinder K; Skjødt K
J Immunol; 1992 Mar; 148(5):1532-46. PubMed ID: 1538136
[TBL] [Abstract][Full Text] [Related]
6. Beta-chain broadens range of CD8 recognition for MHC class I molecule.
Karaki S; Tanabe M; Nakauchi H; Takiguchi M
J Immunol; 1992 Sep; 149(5):1613-8. PubMed ID: 1506684
[TBL] [Abstract][Full Text] [Related]
7. Functional dissociation of CD8 alpha's Ig homologue and connecting peptide domains.
Meyerson HJ; Huang JH; Fayen JD; Tsao HM; Getty RR; Greenspan NS; Tykocinski ML
J Immunol; 1996 Jan; 156(2):574-84. PubMed ID: 8543808
[TBL] [Abstract][Full Text] [Related]
8. Different effects of substitutions at residues 224 and 228 of MHC class I on the recognition of CD8.
Sekimata M; Tanabe M; Sarai A; Yamamoto J; Kariyone A; Nakauchi H; Egawa K; Takiguchi M
J Immunol; 1993 May; 150(10):4416-26. PubMed ID: 8482843
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2.
Gao GF; Tormo J; Gerth UC; Wyer JR; McMichael AJ; Stuart DI; Bell JI; Jones EY; Jakobsen BK
Nature; 1997 Jun; 387(6633):630-4. PubMed ID: 9177355
[TBL] [Abstract][Full Text] [Related]
10. Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells.
Schott E; Ploegh HL
Eur J Immunol; 2002 Dec; 32(12):3425-34. PubMed ID: 12432573
[TBL] [Abstract][Full Text] [Related]
11. T cell receptor/peptide/MHC molecular characterization and standardized pMHC contact sites in IMGT/3Dstructure-DB.
Kaas Q; Lefranc MP
In Silico Biol; 2005; 5(5-6):505-28. PubMed ID: 16268793
[TBL] [Abstract][Full Text] [Related]
12. Requirement for Q226, but not multiple charged residues, in the class I MHC CD loop/D strand for TCR-activated CD8 accessory function.
Durairaj M; Sharma R; Varghese JC; Kane KP
Eur J Immunol; 2003 Mar; 33(3):676-84. PubMed ID: 12616488
[TBL] [Abstract][Full Text] [Related]
13. Low binding capacity of murine tetramers mutated at residue 227 does not preclude the ability to efficiently activate CD8+ T lymphocytes.
Nugent CT; Renteria RO; Kuus-Reichel K; Kumar A
Immunol Lett; 2005 May; 98(2):208-15. PubMed ID: 15860220
[TBL] [Abstract][Full Text] [Related]
14. Structural basis of the differential stability and receptor specificity of H-2Db in complex with murine versus human beta2-microglobulin.
Achour A; Michaëlsson J; Harris RA; Ljunggren HG; Kärre K; Schneider G; Sandalova T
J Mol Biol; 2006 Feb; 356(2):382-96. PubMed ID: 16375919
[TBL] [Abstract][Full Text] [Related]
15. Molecular modelling of co-receptor CD8 alpha alpha and its complex with MHC class I and T-cell receptor in sea bream (Sparus aurata).
Costantini S; Buonocore F; Facchiano AM
Fish Shellfish Immunol; 2008 Dec; 25(6):782-90. PubMed ID: 18951040
[TBL] [Abstract][Full Text] [Related]
16. Design, characterization, and structure of a biologically active single-chain mutant of human IFN-gamma.
Landar A; Curry B; Parker MH; DiGiacomo R; Indelicato SR; Nagabhushan TL; Rizzi G; Walter MR
J Mol Biol; 2000 May; 299(1):169-79. PubMed ID: 10860730
[TBL] [Abstract][Full Text] [Related]
17. A site for CD4 binding in the beta 1 domain of the MHC class II protein HLA-DR1.
Brogdon J; Eckels DD; Davies C; White S; Doyle C
J Immunol; 1998 Nov; 161(10):5472-80. PubMed ID: 9820523
[TBL] [Abstract][Full Text] [Related]
18. The orientation and nature of the interaction between beef insulin-specific TCRs and the insulin/class II MHC complex.
Wither JE; Vukusic B
J Immunol; 1999 Feb; 162(4):2113-22. PubMed ID: 9973485
[TBL] [Abstract][Full Text] [Related]
19. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
[TBL] [Abstract][Full Text] [Related]
20. Human CD8 beta, but not mouse CD8 beta, can be expressed in the absence of CD8 alpha as a beta beta homodimer.
Devine L; Kieffer LJ; Aitken V; Kavathas PB
J Immunol; 2000 Jan; 164(2):833-8. PubMed ID: 10623829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
